Management of the human mucosal defensive barrier: Evidence for glycan legislation

Biological Chemistry

Volumn 390, Issue 7, 2009, Pages 581-590

  Patsos, Georgios ^a,b   Corfield, Anthony ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Gastrointestinal; Glycan; Glycocalyx; Inhibitors; Microflora; Mucin

Indexed keywords

GLYCAN; LIGAND; MUCIN;

ANGIOGENESIS; APOPTOSIS; BACTERIUM; BIRTH; CANCER CELL CULTURE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; COMPARATIVE STUDY; DEVELOPMENTAL STAGE; DOWN REGULATION; ENVIRONMENT; FECES MICROFLORA; GASTROINTESTINAL MUCOSA; GENERAL ASPECTS OF DISEASE; GLYCOBIOLOGY; GLYCOCALYX; GLYCOSYLATION; HOMEOSTASIS; HOST; HUMAN; INTESTINE; INTESTINE EPITHELIUM; INTESTINE FLORA; LAMINA PROPRIA; MICROFLORA; MUCOSA CELL; MUCUS; NONHUMAN; POPULATION; PRIORITY JOURNAL; PROTECTION; REGULATORY MECHANISM; REVIEW; SPECIES; SURGICAL TECHNIQUE; SYNTHESIS; TECHNOLOGY;

ANIMALS; GASTRIC MUCINS; GASTRIC MUCOSA; GLYCOMICS; HUMANS; INTESTINES; POLYSACCHARIDES;

BACTERIA (MICROORGANISMS);

EID: 68149132022     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.052     Document Type: Review

References (112)

1. Asker, N., Baekstrom, D., Axelsson, M.A.B., Carlstedt, I., and Hansson, G.C. (1995). The human MUC2 mucin apoprotein appears to dimerize before O-glycosylation and shares epitopes with the 'insoluble' mucin of rat small intestine. Biochem. J. 308, 873-880.
2. Atuma, C., Strugala, V., Allen, A., and Holm, L. (2001). The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G922-G929.
3. Backhed, F., Ley, R.E., Sonnenburg, J.L., Peterson, D.A., and Gordon, J.I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920.
4. Backhed, F., Manchester, J.K., Semenkovich, C.F., and Gordon, J.I. (2007). Mechanisms underlying the resistance to dietinduced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 104, 979-984.
5. Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M.E., Alvarez, R., Bryan, M.C., Fazio, F., Calarese, D., Stevens, J., et al. (2004). Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101, 17033-17038.
6. Brockhausen, I. (1999). Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1473, 67-95.
7. Brockhausen, I. (2003). Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. Adv. Exp. Med. Biol. 535, 163-188.
8. Brockhausen, I., Yang, J., Dickinson, N., Ogata, S., and Itzkowitz, S.H. (1998). Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconj. J. 15, 595-603.
9. Brown, J.R., Fuster, M.M., Li, R., Varki, N., Glass, C.A., and Esko, J.D. (2006). A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin. Cancer Res. 12, 2894-2901.
10. Butters, T.D., Dwek, R.A., and Platt, F.M. (2005). Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15, 43R-52R.
11. Byrd, J.C. and Bresalier, R.S. (2004). Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23, 77-99.
12. Carraway, K.L., Ramsauer, V.P., Haq, B., and Carothers Carraway, C.A. (2003). Cell signaling through membrane mucins. Bioessays 25, 66-71.
13. Carrington, S.D., Clyne, M., Reid, C.J., FitzPatrick, E., and Corfield, A.P. (2009). Microbial interaction with mucus and mucins. In: Microbial Glycobiology: Structures, Relevance and Applications, A. Moran, P. Brennan, O. Holst and M. von Itzstein, eds. (Amsterdam, Netherlands: Elsevier BV), in press.
14. Chang, V.T., Crispin, M., Aricescu, A.R., Harvey, D.J., Nettleship, J.E., Fennelly, J.A., Yu, C., Boles, K.S., Evans, E.J., Stuart, D.I., et al. (2007). Glycoprotein structural genomics: solving the glycosylation problem. Structure 15, 267-273.
15. Chieppa, M., Rescigno, M., Huang, A.Y., and Germain, R.N. (2006). Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement. J. Exp. Med. 203, 2841-2852.
16. Comelli, E.M., Head, S.R., Gilmartin, T., Whisenant, T., Haslam, S.M., North, S.J., Wong, N.K., Kudo, T., Narimatsu, H., Esko, J.D., et al. (2006). A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 16, 117-131.
17. Coombes, J.L. and Maloy, K.J. (2007). Control of intestinal homeostasis by regulatory T cells and dendritic cells. Sem. Immunol. 19, 116-126.
18. Corfield, A.P. (2000). Glycoprotein Methods and Protocols: The Mucins (Totowa, NJ, USA: Humana Press).
19. Corfield, A.P. (2007). Glycobiology of mucins in the human gastrointestinal tract. In: Glycobiology, C. Sansom and O. Markman, eds. (Bloxham, UK: Scion Publishing Ltd.), pp. 248-260.
20. Corfield, A.P., Wagner, S.A., Clamp, J.R., Kriaris, M.S., and Hoskins, L.C. (1992). Mucin degradation in the human colon: production of sialidase, sialate O-acetyl esterase, N-acetyl-neuraminate lyase, arylesterase and glycosulfatase activities by strains of fecal bacteria. Infect. Immun. 60, 3971-3978.
21. Corfield, A.P., Wagner, S.A., O'Donnell, L.J., Durdey, P., Mountford, R.A., and Clamp, J.R. (1993). The roles of enteric bacterial sialidase, sialate O-acetyl esterase and glycosulfatase in the degradation of human colonic mucin. Glycoconj. J. 10, 72-81.
22. Corfield, A.P., Carroll, D., Myerscough, N., and Probert, C.S. (2001). Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6, D1321-D1357.
23. Dekker, J., Rossen, J.W., Buller, H.A., and Einerhand, A.W. (2002). The MUC family: an obituary. Trends Biochem. Sci. 27, 126-131.
24. Delacour, D., Gouyer, V., Leteurtre, E., Ait-Slimane, T., Drobecq, H., Lenoir, C., Moreau-Hannedouche, O., Trugnan, G., and Huet, G. (2003). 1-benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside blocks the apical biosynthetic pathway in polarized HT-29 cells. J. Biol. Chem. 278, 37799-37809.
25. Deplancke, B. and Gaskins, H.R. (2001). Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 73, 1131S-1141S.
26. Desseyn, J.-L., Gouyer, V., and Tetaert, D. (2008). Architecture of the gel forming mucins, In: The Epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory Diseases, I. Van Seuningen, ed. (Kerala, India: Research Signpost), pp. 1-16.
27. Disney, M.D. and Seeberger, P.H. (2004). The use of carbohydrate microarrays to study carbohydrate-cell interations and to detect pathogens. Chem. Biol. 11, 1701-1707.
28. Dwek, R.A., Butters, T.D., Platt, F.M., and Zitzmann, N. (2002). Targeting glycosylation as a therapeutic approach. Nat. Rev. Drug Discov. 1, 65-75.
29. Edwards, C.M. and Corfield, A.P. (2000). Mucin bound O-acetylated sialic acids and diversion colitis. Gut 46, A81.
30. Feizi, T., Fazio, F., Chai, W., and Wong, C.H. (2003). Carbohydrate microarrays - a new set of technologies at the frontiers of glycomics. Curr. Opin. Struct. Biol. 13, 637-645.
31. Fuster, M.M. and Esko, J.D. (2005). The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 5, 526-542.
32. Gabius, H.-J. (2008). The Sugar Code. Fundamentals of Glycoscience (Weinheim, Germany: Wiley-VCH).
33. Gagneux, P. and Varki, A. (1999). Evolutionary and considerations in relating oligosaccharide diversity to biological functions. Glycobiology 9, 744-755.
34. Godl, K., Johansson, M.E., Lidell, M.E., Morgelin, M., Karlsson, H., Olson, F.J., Gum, J.R. Jr., Kim, Y.S., and Hansson, G.C. (2002). The N terminus of the MUC2 mucin forms trimers that are held together within a trypsin-resistant core fragment. J. Biol. Chem. 277, 47248-47256.
35. Gouyer, V., Leteurtre, E., Zanetta, J.P., Lesuffleur, T., Delannoy, P., and Huet, G. (2001). Inhibition of the glycosylation and alteration in the intracellular trafficking of mucins and other glycoproteins by GalNAcα-O-bn in mucosal cell lines: an effect mediated through the intracellular synthesis of complex GalNAca-O-bn oligosaccharides. Front. Biosci. 6, D1235-D1244.
36. Groux-Degroote, S., Harduin-Lepers, A., and Delannoy, P. (2008). Biosynthesis of mucin O-glycan chains in normal and pathological states. In: The Epithelial Mucins: Structure/ Function. Roles in Cancer and Inflammatory Diseases, I. Van Seuningen, ed. (Kerala, India: Research Signpost), pp. 39-54.
37. Guarner, F. and Malagelada, J.R. (2003). Gut flora in health and disease. Lancet 361, 512-519.
38. Gupta, R., Birch, H., Rapacki, K., Brunak, S., and Hansen, J.E. (1999). O-GLYCBASE version 4.0: a revised database of O-glycosylated proteins. Nucleic Acids Res. 27, 370-372.
39. Haltiwanger, R.S., Grove, K., and Philipsberg, G.A. (1998). Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-β-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem. 273, 3611-3617.
40. Hart, G.W., Housley, M.P., and Slawson, C. (2007). Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446, 1017-1022.
41. Hashimoto, K., Goto, S., Kawano, S., Aoki-Kinoshita, K.F., Ueda, N., Hamajima, M., Kawasaki, T., and Kanehisa, M. (2006). KEGG as a glycome informatics resource. Glycobiology 16, 63R-70R.
42. Hattrup, C.L. and Gendler, S.J. (2008). Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431-457.
43. Hennebicq-Reig, S., Lesuffleur, T., Capon, C., De Bolos, C., Kim, I., Moreau, O., Richet, C., Hemon, B., Recchi, M.A., Maes, E., et al. (1998). Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-α-D- galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem. J. 334, 283-295.
44. Hollingsworth, M.A. and Swanson, B.J. (2004). Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4, 45-60.
45. Hooper, L.V. and Gordon, J.I. (2001). Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity. Glycobiology 11, 1R-10R.
46. Hoskins, L.C. (1993). Mucin degradation in the human gastrointestinal tract and its significance to enteric microbial ecology. Eur. J. Gastroenterol. Hepatol. 5, 205-213.
47. Huet, G., Gouyer, V., Delacour, D., Richet, C., Zanetta, J.P., Delannoy, P., and Degand, P. (2003). Involvement of glycosylation in the intracellular trafficking of glycoproteins in polarized epithelial cells. Biochimie 85, 323-330.
48. Ito, S. (1969). Structure and function of the glycocalyx. Fed. Proc. 28, 12-25.
49. Jonckheere, N. and Van Seuningen, I. (2008). The ever growing family of membrane-bound mucins. In: The Epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory Diseases, I. Van Seuningen, ed. (Kerala, India: Research Signpost), pp. 17-38.
50. Jones, J.L. and Foxx-Orenstein, A.E. (2007). The role of probiotics in inflammatory bowel disease. Dig. Dis. Sci. 52, 607-611.
51. Kagnoff, M.F. and Eckmann, L. (1997). Epithelial cells as sensors for microbial infection. J. Clin. Invest. 100, 6-10.
52. Keller, M. and Zengler, K. (2004). Tapping into microbial diversity. Nat. Rev. Microbiol. 2, 141-150.
53. Kjellev, S., Nexo, E., Thim, L., and Poulsen, S.S. (2006). Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents. Br. J. Pharmacol. 149, 92-99.
54. Komatsu, M., Arango, M.E., and Carraway, K.L. (2002). Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis. Biochem. J. 368, 41-48.
55. Laine, R.A. (1997). The information-storing potential of the sugar code. In: Glycosciences, Status and Perspectives, H.-J. Gabius and S. Gabius, eds. (Weinheim, Germany: Chapman and Hall), pp. 1-14.
56. Leteurtre, E., Gouyer, V., Delacour, D., Hemon, B., Pons, A., Richet, C., Zanetta, J.P., and Huet, G. (2003). Induction of a storage phenotype and abnormal intracellular localization of apical glycoproteins are two independent responses to GalNAca-O-bn. J. Histochem. Cytochem. 51, 349-361.
57. Levitin, F., Baruch, A., Weiss, M., Stiegman, K., Hartmann, M.L., Yoeli-Lerner, M., Ziv, R., Zrihan-Licht, S., Shina, S., Gat, A., et al. (2005). A novel protein derived from the MUC1 gene by alternative splicing and frameshifting. J. Biol. Chem. 280, 10655-10663.
58. Ley, R.E., Turnbaugh, P.J., Klein, S., and Gordon, J.I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
59. Lidell, M.E., Johansson, M.E., and Hansson, G.C. (2003a). An autocatalytic cleavage in the C-terminus of the human MUC2 mucin occurs at the low pH of the late secretory pathway. J. Biol. Chem. 278, 13944-13951.
60. Lidell, M.E., Johansson, M.E., Morgelin, M., Asker, N., Gum, J.R. Jr., Kim, Y.S., and Hansson, G.C. (2003b). The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem. J. 372, 335-345.
61. Lievin-Le Moal, V. and Servin, A.L. (2006). The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clin. Microbiol. Rev. 19, 315-337.
62. Linden, S.K., Sutton, P., Karlsson, N.G., Korolik, V., and McGuckin, M.A. (2008). Mucins in the mucosal barrier to infection. Mucosal Immunol. 1, 183-197.
63. Lu, J., The, C., Kishore, U., and Reid, K.B. (2002). Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta 1572, 387-400.
64. Lutteke, T., Bohne-Lang, A., Loss, A., Goetz, T., Frank, M., and von der Lieth, C.W. (2006). GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research. Glycobiology 16, 71R-81R.
65. Macao, B., Johansson, D.G., Hansson, G.C., and Hard, T. (2006). Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol. 13, 71-76.
66. Macpherson, A.J. and Harris, N.L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485.
67. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., et al. (2006). Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55, 205-211.
68. Mowat, A.M. (2003). Anatomic basis of tolerance and immunityn to intestinal antigens. Nat. Rev. Immunol. 3, 331-341.
69. Mueller, C. and Macpherson, A.J. (2006). Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 55, 276-284.
70. Nadel, J.A. (2001). Role of epidermal growth factor receptor activation in regulating mucin synthesis. Respir. Res. 2, 85-89.
71. Palmer, C.N., Bik, E.M., DiGiulio, D.B., Relman, D.A., and Brown, P.O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5, 1-18.
72. Patsos, G. and Corfield, A. (2009). O-Glycosylation: structural diversity and functions. In: The Sugar Code. Fundamentals of Glycoscience, H.-J. Gabius, ed. (Weinheim, Germany: Wiley-VCH), in press.
73. Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., San Martin, R., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J.-C., et al. (2009). O-glycan inhibitors generate aryl-glycans induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. Glycobiology 19, 382-398.
74. Paulson, J.C., Blixt, O., and Collins, B.E. (2006). Sweet spots in functional glycomics. Nat. Chem. Biol. 2, 238-248.
75. Perrais, M., Pigny, P., Copin, M.C., Aubert, J.P., and Van Seuningen, I. (2002). Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J. Biol. Chem. 277, 32258-32267.
76. Price-Schiavi, S.A., Andrechek, E., Idris, N., Li, P., Rong, M., Zhang, J., Carothers Carraway, C.A., Muller, W.J., and Car-raway, K.L. (2005). Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy. J. Cell Physiol. 203, 44-53.
77. Radtke, F. and Clevers, H. (2005). Self-renewal and cancer of the gut: two sides of a coin. Science 307, 1904-1909.
78. Raj, P.A. and Dentino, A.R. (2002). Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol. Lett. 206, 9-18.
79. Ratner, D.M., Adams, E.W., Disney, M.D., and Seeberger, P.H. (2004). Tools for glycomics: mapping interactions of carbohydrates in biological systems. ChemBioChem 5, 1375-1383.
80. Ren, J., Agata, N., Chen, D., Li, Y., Yu, W.H., Huang, L., Raina, D., Chen, W., Kharbanda, S., and Kufe, D. (2004). Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell 5, 163-175.
81. Reya, T. and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature 434, 843-850.
82. Rose, M.C. and Voynow, J.A. (2006). Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 86, 245-278.
83. Rudd, P.M., Elliott, T., Cresswell, P., Wilson, I.A., and Dwek, R.A. (2001). Glycosylation and the immune system. Science 291, 2370-2376.
84. Sonnenburg, J.L., Angenent, L.T., and Gordon, J.I. (2004). Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat. Immunol. 5, 569-573.
85. Sonnenburg, J.L., Xu, J., Leip, D.D., Chen, C.H., Westover, B.P., Weatherford, J., Buhler, J.D., and Gordon, J.I. (2005). Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 307, 1955-1959.
86. Stevens, J., Blixt, O., Glaser, L., Taubenberger, J.K., Palese, P., Paulson, J.C., and Wilson, I.A. (2006). Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355, 1143-1155.
87. Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening-Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002). Mucosal flora in inflammatory bowel disease. Gastroenterology 122, 44-54.
88. Swidsinski, A., Loening-Baucke, V., Theissig, F., Engelhardt, H., Bengmark, S., Koch, S., Lochs, H., and Dorffel, Y. (2007a). Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 56, 343-350.
89. Swidsinski, A., Sydora, B.C., Doerffel, Y., Loening-Baucke, V., Vaneechoutte, M., Lupicki, M., Scholze, J., Lochs, H., and Dieleman, L.A. (2007b). Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflamm. Bowel Dis. 13, 963-970.
90. Taylor, M.E. and Drickamer, K. (2003). Introduction to Glycobiology (Oxford, UK: Oxford University Press).
91. Thomsson, K.A., Schulz, B.L., Packer, N.H., and Karlsson, N.G. (2005). MUC5B glycosylation in human saliva reflects blood group and secretory status. Glycobiology 15, 791-804.
92. Thornton, D.J., Rousseau, K., and McGuckin, M.A. (2008). Structure and function of the polymeric mucins in airway mucus. Annu. Rev. Physiol. 70, 459-486.
93. Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., and Gordon, J.I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
94. Turnbull, J.E. and Field, R.A. (2007). Emerging glycomics technologies. Nat. Chem. Biol. 3, 74-77.
95. Ulloa, F. and Real, F.X. (2003). Benzyl-N-acetyl-α-D- galactosaminide induces a storage disease-like phenotype by perturbing the endocytic pathway. J. Biol. Chem. 278, 12374-12383.
96. Ulloa, F., Franci, C., and Real, F.X. (2000). GalNAcα-O-benzyl inhibits sialylation of de novo synthesized apical but not basolateral sialoglycoproteins and blocks lysosomaml enzyme processing in a post-TGN compartment. J. Biol. Chem. 275, 18785-18793.
97. Van den Steen, P., Rudd, P.M., Dwek, R.A., and Opdenakker, G. (1998). Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33, 151-208.
98. Van Seuningen, I. (2008). The Epithelial Mucins: Structure/Function. Roles in Cancer and Inflammatory Diseases (Kerala, India: Research Signpost).
99. Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130.
100. Varki, A. (2006). Nothing in glycobiology makes sense, except in the light of evolution. Cell 126, 841-845.
101. Varki, A., Cummings, R.D., Esko, J., Freeze, H., Stanley, P., Bertozzi, C., Hart, G., and Etzler, M.E. (2008). Essentials of Glycobiology, 2nd Edition (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press).
102. Villalobo, A., Nogales-Gonzalez, A., and Gabius, H.J. (2006). A guide to signalling pathways connecting protein-glycan interactions with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci. Glycotechnol. 18, 1-37.
103. Winans, K.A. and Bertozzi, C.R. (2002). An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation. Chem. Biol. 9, 113-129.
104. Winchester, B. (2007). The development of iminosugars as drugs. In: Glycobiology, C. Sansom and O. Markman, eds. (Bloxham, UK: Scion Publishing Ltd.), pp. 308-324.
105. Wreschner, D.H., McGuckin, M.A., Williams, S.J., Baruch, A., Yoeli, M., Ziv, R., Okun, L., Zaretsky, J., Smorodinsky, N., Keydar, I., et al. (2002). Generation of ligand-receptor alliances by 'SEA' module-mediated cleavage of membrane-associated mucin proteins. Protein Sci. 11, 698-706.
106. Xavier, R.J. and Podolsky, D.K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
107. Xu, J. and Gordon, J.I. (2003). Inaugural article: honor thy symbionts. Proc. Natl. Acad. Sci. USA 100, 10452-10459.
108. Xu, J., Mahowald, M.A., Ley, R.E., Lozupone, C.A., Hamady, M., Martens, E.C., Henrissat, B., Coutinho, P.M., Minx, P., Latreille, P., et al. (2007). Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 5, e156.
109. Yin, L., Li, Y., Ren, J., Kuwahara, H., and Kufe, D. (2003). Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J. Biol. Chem. 278, 35458-35464.
110. Yu, L.G., Andrews, N., Zhao, Q., McKean, D., Williams, J.F., Connor, L.J., Gerasimenko, O.V., Hilkens, J., Hirabayashi, J., Kasai, K., et al. (2007). Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J. Biol. Chem. 282, 773-781.
111. Zanetta, J.P., Gouyer, V., Maes, E., Pons, A., Hemon, B., Zweibaum, A., Delannoy, P., and Huet, G. (2000) Massive in vitro synthesis of tagged oligosaccharides in 1-benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside treated HT-29 cells. Glycobiology 10, 565-575.
112. Zitzmann, N., Block, T., Methta, A., Rudd, P., Burton, D., Wilson, I., Platt, F., Butters, T., and Dwek, R.A. (2005). Glycosylation: disease targets and therapy. Adv. Exp. Med. Biol. 564, 1-2.